Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sebelius Defends Device Tax And HHS 2012 Budget Request On The Hill

This article was originally published in The Gray Sheet

Executive Summary

Republican efforts to repeal the device tax were met with resistance from Health and Human Services Secretary Kathleen Sebelius, who defended the tax during a Feb. 16 House Ways and Means Committee hearing on the president's fiscal year 2012 budget request.

You may also be interested in...



NIH Translational Science Center Defended On Capitol Hill

NIH Director Francis Collins March 20 defends his newly formed National Center for Advancing Translational Science, which is aimed at turning new diagnostic and therapeutic discoveries into viable products, before a highly suspicious House Appropriations Labor-HHS Subcommittee.

Debate Over Device Tax Guidance Divides Hospitals, MedTech Groups

Hospitals and group purchasers are pressing the Internal Revenue Service to develop regulations that would make it more difficult for medical technology firms to pass the costs of the upcoming device excise tax onto customers.

Debate Over Device Tax Guidance Divides Hospitals, MedTech Groups

Hospitals and group purchasers are pressing the Internal Revenue Service to develop regulations that would make it more difficult for medical technology firms to pass the costs of the upcoming device excise tax onto customers.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel